Drawing on his experiences as a top executive at Alibaba Group, David Wei fashioned Vision Knight Capital into a China-focused private equity firm that aims to be both consultant and capital provider
When David Wei left his position as CEO of Alibaba Group’s then Hong Kong-listed B2B marketplace in 2011, he didn’t consider launching a business of his own: there was little chance of topping Alibaba...
Black Sesame Technologies, a China-based chipmaker specializing in autonomous driving applications, has closed a Series C extension led by SummitView Capital. This brings the size of the overall round to USD 500m.
Japanese lower middle-market private equity firm J-Star has made an investment of undisclosed size in air cargo transportation and courier services provider Score Japan Holdings.
Gaorong Capital and Tsing Song Capital have led a CNY 500m (USD 74m) Series C for IntellectiveBio, a China-based contract development and manufacturing organisation (CDMO).
Morningside Venture Capital has teamed up with Kingray Capital, Trinity Innovation Fund, TigerYeah Capital, and FountainBridge Capital to provide USD 20m in angel and pre-Series A funding for Epigenic Therapeutics, a China-based gene editing specialist.